Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Zacks research out dated July 1

View:

Post by Amigo11 on Jul 02, 2021 6:58am

Zacks research out dated July 1

Found a new update from Zacks on Yahoo Finance -excellent breakdown of the activities next 3 quarters-woooowhoooo-a roadmap

290

Comment

Comment by GameChangerBet on Jul 02, 2021 8:58am

https://finance.yahoo.com/news/ate-phase-3-enabling-activities-110700125.html

203

Comment

Comment by 123ABC on Jul 02, 2021 10:39am

lol

Comment

Comment by baggerx99 on Jul 02, 2021 3:14pm

Antibe is well on its way to getting the Phase 3 program for otenaproxesul underway with the initiation of the AME trial starting very soon. We don’t anticipate any issues with the company completing that trial in a timely manner and it should lead to the initiation of the Phase 3 adaptive trial in the first quarter of 2022. While partnering efforts are underway for the large global markets, it ...more

229

Comment

Antibe Therapeutics Inc(Pre-Merger)